MA26745A1 - Diphosphate d'un derive de 9-deoxo-9a-aza-9a-homoerythromycine substituee en 4", son procede de preparation et composition pharmaceutique le contenant - Google Patents

Diphosphate d'un derive de 9-deoxo-9a-aza-9a-homoerythromycine substituee en 4", son procede de preparation et composition pharmaceutique le contenant

Info

Publication number
MA26745A1
MA26745A1 MA26011A MA26011A MA26745A1 MA 26745 A1 MA26745 A1 MA 26745A1 MA 26011 A MA26011 A MA 26011A MA 26011 A MA26011 A MA 26011A MA 26745 A1 MA26745 A1 MA 26745A1
Authority
MA
Morocco
Prior art keywords
homoerythromycin
deoxo
diphosphate
aza
derivative
Prior art date
Application number
MA26011A
Other languages
English (en)
Inventor
John Rafka Robert
Brendan Ragan Colman
John Meldrum Allen Douglas
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MA26745A1 publication Critical patent/MA26745A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MA26011A 1999-06-30 2000-06-28 Diphosphate d'un derive de 9-deoxo-9a-aza-9a-homoerythromycine substituee en 4", son procede de preparation et composition pharmaceutique le contenant MA26745A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14168199P 1999-06-30 1999-06-30

Publications (1)

Publication Number Publication Date
MA26745A1 true MA26745A1 (fr) 2004-12-20

Family

ID=22496734

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26011A MA26745A1 (fr) 1999-06-30 2000-06-28 Diphosphate d'un derive de 9-deoxo-9a-aza-9a-homoerythromycine substituee en 4", son procede de preparation et composition pharmaceutique le contenant

Country Status (42)

Country Link
US (3) US6465437B1 (fr)
EP (1) EP1189913B1 (fr)
JP (1) JP2003503506A (fr)
KR (1) KR100442508B1 (fr)
CN (2) CN101220067A (fr)
AP (1) AP2001002370A0 (fr)
AR (1) AR035551A1 (fr)
AT (1) ATE286906T1 (fr)
AU (1) AU772277B2 (fr)
BG (1) BG65587B1 (fr)
BR (1) BR0012091A (fr)
CA (1) CA2376748C (fr)
CO (1) CO5190679A1 (fr)
CZ (1) CZ20014571A3 (fr)
DE (1) DE60017399T2 (fr)
EA (1) EA004235B1 (fr)
EC (1) ECSP003555A (fr)
EE (1) EE05068B1 (fr)
ES (1) ES2233380T3 (fr)
GT (2) GT200000105AA (fr)
HN (1) HN2000000090A (fr)
HR (1) HRP20010919B1 (fr)
HU (1) HUP0201693A3 (fr)
IL (1) IL146408A0 (fr)
IS (1) IS6159A (fr)
MA (1) MA26745A1 (fr)
MX (1) MXPA02000058A (fr)
MY (1) MY133360A (fr)
NO (1) NO20016221L (fr)
OA (1) OA11965A (fr)
PA (1) PA8496901A1 (fr)
PE (1) PE20010287A1 (fr)
PL (1) PL201891B1 (fr)
PT (1) PT1189913E (fr)
SK (1) SK286243B6 (fr)
TN (1) TNSN00143A1 (fr)
TR (1) TR200103834T2 (fr)
UA (1) UA71013C2 (fr)
UY (1) UY26221A1 (fr)
WO (1) WO2001002414A1 (fr)
YU (1) YU88701A (fr)
ZA (1) ZA200110453B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
US6791660B1 (en) * 2002-02-12 2004-09-14 Seiko Epson Corporation Method for manufacturing electrooptical device and apparatus for manufacturing the same, electrooptical device and electronic appliances
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
WO2013013834A1 (fr) 2011-07-27 2013-01-31 Farma Grs, D.O.O. Nouvelles formes cristallines de tulathromycine
CN106008622A (zh) * 2016-08-02 2016-10-12 海门慧聚药业有限公司 泰拉霉素新晶型及其制备
CN110885351A (zh) * 2019-12-17 2020-03-17 海门慧聚药业有限公司 泰拉霉素磷酸盐的晶型及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
SI9011409A (en) * 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
JP2003512290A (ja) * 1997-09-10 2003-04-02 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての８ａ−アザライド
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
DK1189912T3 (da) * 1999-05-18 2008-06-30 Pfizer Prod Inc Nye krystallinske former af et makrolid antibiotikum
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition

Also Published As

Publication number Publication date
OA11965A (en) 2006-04-12
KR20020016875A (ko) 2002-03-06
CZ20014571A3 (cs) 2002-04-17
BR0012091A (pt) 2002-04-02
UA71013C2 (uk) 2004-11-15
EA004235B1 (ru) 2004-02-26
GT200000105AA (es) 2001-12-20
AU4943900A (en) 2001-01-22
EP1189913A1 (fr) 2002-03-27
NO20016221D0 (no) 2001-12-19
AU772277B2 (en) 2004-04-22
TR200103834T2 (tr) 2002-05-21
US20030092642A1 (en) 2003-05-15
YU88701A (sh) 2004-09-03
PE20010287A1 (es) 2001-03-05
BG65587B1 (bg) 2009-01-30
SK286243B6 (sk) 2008-06-06
CO5190679A1 (es) 2002-08-29
NO20016221L (no) 2001-12-19
KR100442508B1 (ko) 2004-07-30
EP1189913B1 (fr) 2005-01-12
PL201891B1 (pl) 2009-05-29
UY26221A1 (es) 2001-01-31
DE60017399D1 (de) 2005-02-17
BG106123A (en) 2002-05-31
US6465437B1 (en) 2002-10-15
US20040209826A1 (en) 2004-10-21
EA200101178A1 (ru) 2002-06-27
MXPA02000058A (es) 2002-07-02
CA2376748C (fr) 2006-03-14
CN101220067A (zh) 2008-07-16
EE200100699A (et) 2003-02-17
US6861412B2 (en) 2005-03-01
ZA200110453B (en) 2003-03-04
US7297682B2 (en) 2007-11-20
PL352900A1 (en) 2003-09-22
HUP0201693A3 (en) 2003-03-28
HN2000000090A (es) 2001-04-20
AP2001002370A0 (en) 2001-12-31
ECSP003555A (es) 2002-01-25
GT200000105A (es) 2001-12-20
WO2001002414A1 (fr) 2001-01-11
PA8496901A1 (es) 2002-08-26
IL146408A0 (en) 2002-07-25
AR035551A1 (es) 2004-06-16
CN1358188A (zh) 2002-07-10
DE60017399T2 (de) 2006-03-30
MY133360A (en) 2007-11-30
SK18922001A3 (sk) 2002-04-04
HUP0201693A2 (en) 2002-10-28
PT1189913E (pt) 2005-04-29
HRP20010919A2 (en) 2003-02-28
HRP20010919B1 (en) 2005-06-30
IS6159A (is) 2001-11-13
ATE286906T1 (de) 2005-01-15
EE05068B1 (et) 2008-08-15
ES2233380T3 (es) 2005-06-16
JP2003503506A (ja) 2003-01-28
CA2376748A1 (fr) 2001-01-11
TNSN00143A1 (fr) 2005-11-10

Similar Documents

Publication Publication Date Title
MA26687A1 (fr) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2783246B1 (fr) Derives d'azetidine, leur preparation et les medicaments les contenant
MA26614A1 (fr) Bicyclo [2.2.1] heptanes nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26471A1 (fr) Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2780057B1 (fr) Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26415A1 (fr) Composes heterocycliques, procede pour la preparation et compositions pharmaceutiques les contenant
MA26472A1 (fr) Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26686A1 (fr) Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2729951B1 (fr) Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant
MA26479A1 (fr) Derives de nicotinamide, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2735777B1 (fr) Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
MA26424A1 (fr) Derives de 6-phenylpyridyl-2-amine, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26630A1 (fr) 4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26433A1 (fr) Derives de pyridylpyrrole, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26558A1 (fr) Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26499A1 (fr) Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant .
MA26505A1 (fr) Derives de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2636628B1 (fr) Derives du thiadiazole-1,3,4, leur procede d'obtention et compositions pharmaceutiques en contenant
FR2671086B1 (fr) Peptides opiouides, leur procede de preparation, et composition pharmaceutique contenant ces peptides.
MA26567A1 (fr) Trifluoromethylethers cycliques a fonction piperidinylaminomethule, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26501A1 (fr) Derives de quinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26552A1 (fr) Derives d'isoquinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26417A1 (fr) Azetidines, procede pour leur preparation, et compositions pharmaceutiques les contenant
MA26582A1 (fr) Derives de thiazolidinedione nouveau, procede pour sa preparation et composition pharmaceutique le contenant
FR2687401B1 (fr) Derives de la 1,4-dialkylpiperazine, procedes d'obtention et compositions pharmaceutiques les contenant.